These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18634926)

  • 61. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth.
    Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S
    Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CAT of the month. Mineral trioxide aggregate (MTA) successful for pulpotomy treatment (UT CAT #2296).
    Alsalman Z; Philip J; Norling B
    Tex Dent J; 2012 Oct; 129(10):1074. PubMed ID: 23311027
    [No Abstract]   [Full Text] [Related]  

  • 63. Calcium Hydroxide Paste, Mineral Trioxide Aggregate, and Formocresol as Direct Pulp Capping Agents in Primary Molars: A Randomized Controlled Clinical Trial.
    ElSebaai A; Wahba AH; Grawish ME; Elkalla IH
    Pediatr Dent; 2022 Nov; 44(6):411-417. PubMed ID: 36947754
    [No Abstract]   [Full Text] [Related]  

  • 64. Assessment of MMP levels in reversible and irreversible pulpitis and a randomized controlled trial comparing clinical success of two different calcium-silicate cements in pulpotomy treatment of primary molars with an 18-month follow-up.
    Gerihan HE; Çoğulu D; Önçağ Ö; Durmaz A; Kuru EH
    BMC Oral Health; 2024 Aug; 24(1):1020. PubMed ID: 39215293
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial.
    Zurn D; Seale NS
    Pediatr Dent; 2008; 30(1):34-41. PubMed ID: 18402097
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.
    Sushynski JM; Zealand CM; Botero TM; Boynton JR; Majewski RF; Shelburne CE; Hu JC
    Pediatr Dent; 2012; 34(5):120-8. PubMed ID: 23211896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current concepts in vital pulpotomies in primary teeth.
    Castro A
    J Mich Dent Assoc; 2005 Jan; 87(1):26-8. PubMed ID: 15714830
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and radiographic evaluation of pulpotomies in primary molars with formocresol, glutaraldehyde and ferric sulphate.
    Havale R; Anegundi RT; Indushekar K; Sudha P
    Oral Health Dent Manag; 2013 Mar; 12(1):24-31. PubMed ID: 23474578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mineral trioxide aggregate pulpotomy of a primary second molar in a patient with agenesis of the permanent successor.
    Moretti AB; Oliveira TM; Sakai VT; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2007 Sep; 40(9):738-45. PubMed ID: 17608676
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative evaluation of pro-inflammatory cytokine levels in pulpotomized primary molars.
    Ozdemir Y; Kutukculer N; Topaloglu-Ak A; Kose T; Eronat C
    J Oral Sci; 2015 Jun; 57(2):145-50. PubMed ID: 26062864
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Partial Pulpotomy in Immature Permanent Molars After Carious Exposures Using Different Hemorrhage Control and Capping Materials.
    Özgür B; Uysal S; Güngör HC
    Pediatr Dent; 2017 Sep; 39(5):364-370. PubMed ID: 29070158
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term effectiveness of four pulpotomy techniques: 3-year randomised controlled trial.
    Huth KC; Hajek-Al-Khatar N; Wolf P; Ilie N; Hickel R; Paschos E
    Clin Oral Investig; 2012 Aug; 16(4):1243-50. PubMed ID: 21842145
    [TBL] [Abstract][Full Text] [Related]  

  • 73. One-year radiographic and clinical performance of bioactive materials in primary molar pulpotomy: A randomized controlled trial.
    Abdelwahab DH; Kabil NS; Badran AS; Darwish D; Abd El Geleel OM
    J Dent; 2024 Apr; 143():104864. PubMed ID: 38281619
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives.
    Fuks AB
    J Endod; 2008 Jul; 34(7 Suppl):S18-24. PubMed ID: 18565366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vital pulp therapy with new materials for primary teeth: new directions and Treatment perspectives.
    Fuks AB
    Pediatr Dent; 2008; 30(3):211-9. PubMed ID: 18615986
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Success rates of mineral trioxide aggregate, ferric sulfate, and sodium hypochlorite pulpotomies: A prospective 24-month study.
    Lin YT; Lin YJ
    J Formos Med Assoc; 2020 Jun; 119(6):1080-1085. PubMed ID: 31635844
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth.
    Barrieshi-Nusair KM; Qudeimat MA
    J Endod; 2006 Aug; 32(8):731-5. PubMed ID: 16861071
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1-year follow-up.
    Shabzendedar M; Mazhari F; Alami M; Talebi M
    Pediatr Dent; 2013; 35(4):329-32. PubMed ID: 23930631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment Outcomes of Mineral Trioxide Aggregate Pulpotomy in Vital Permanent Teeth with Carious Pulp Exposure: The Retrospective Study.
    Linsuwanont P; Wimonsutthikul K; Pothimoke U; Santiwong B
    J Endod; 2017 Feb; 43(2):225-230. PubMed ID: 28041685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.